Clinical Trial Update: Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This document provides an update on an extension study of tosedostat for relapsed/refractory acute myeloid leukemia (Phase 2). The current status of the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tosedostat (tosedostat)

Snippet

Sponsor: Chroma Therapeutics | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN